Evaluation of serum C-reactive Protein level and its related factors in hemodialysis patients in Sari, Iran

Pakistan Journal of Biological Sciences

Volumn 14, Issue 10, 2011, Pages 595-599

  Baradari, Afshin Gholipour ^a   Zeydi, Amir Emami ^a   Espahbodi, Fatemeh ^a   Shahmohammadi, Soheyla ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C reactive protein; Dialysis; End stage renal disease; Hemodialysis; Inflammation; Phosphorus

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INFLAMMATION; IRAN; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; IRAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 80054704085     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2011.595.599     Document Type: Article

References (24)

1. Al-Hamdan, A.A., R.H. Al-Huthail, M.A. Alsaif, A.M. Al-Othman, M.N. Al-Muammer et al., 2009. The effect of weight reduction diet on C-reactive protein level in obese-adult subjects. J. Med. Sci., 9: 17-23.
2. Avram, M.M., P.A. Fein, M. Paluch, T. Schloth and J. Chattopadhyay, 2005. Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients. Adv. Peritoneal Dialysis, 21: 154-158.
3. Baradaran, A. and N. Hamid, 2005. Association of serum c-reactive protein (CRP) with some nutritional parameters of maintenance hemodialysis patients. Pak. J. Nutr., 4: 175-182.
4. Calo, L.A., V. Savica, A. Piccoli, M. Fusaro, A. D'Angelo and P.A. Davis, 2011. Reduction of hyperphosphatemia is related with the reduction of c-reactive protein in dialysis patients. Study in sevelamer-resistant dialysis patients treated with chitosan chewing gum as salivary phosphate binder. Renal. Failure., 33: 11-14.
5. Collins, A.J., S. Li, D.T. Gilbertson, J. Liu, S.C. Chen and C.A. Herzog, 2003. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney. Int., 64: S24-S31.
6. Ducloux, D., C. Bresson-Vautrin, M. Kribs, A. Abdelfatah and J.M. Chalopin, 2002. C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney. Int., 62: 1417-1422.
7. Hung, A., L. Pupim, C. Yu, A. Shintani and E. Siew et al., 2008. Determinants of C-reactive protein in chronic hemodialysis patients: Relevance of dialysis catheter utilization. Hemodialysis. Int., 12: 236-243.
8. Iseki, K., M. Tozawa, S. Yoshi and K. Fukiyama, 1999. Serum C-reactive Protein (CRP) and risk of death in chronic dialysis patients. Nephrol. Dial. Transplant., 14: 1956-1960.
9. Kalantar-zadeh, K., T.A. lkizler, G. Block, M.M. Avram and J.D. Kopple, 2003. Malnutrition-inflamation complex syndrome in dialysis patients: Cause and consequences. Am. J. Kidney. Dis., 42: 864-881.
10. Korevaar, J.C., J.G. van Manen, F.W. Dekker, D.R. de Waart, E.W. Boeschoten and R.T. Krediet, 2004. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality. J. Am. Soc. Nephrol., 15: 2916-2922.
11. Nascimento, M.M., R. Pecoits-Filho, A.R. Qureshi, S.Y. Hayashi and R.C. Manfro et al., 2004. The prognostic impact of fluctuating levels of C-reactive proteins in Brazilian haemodialysis patients: A prospective study. Nephrol. Dial. Transplant., 19: 2803-2809.
12. Nasri, H., S. Shirani and A. Baradaran, 2006a. Association of platelet count and mean platelet volume with serum C-reactive protein in regular hemodialysis patients. Asian J. Cell Biol., 1: 59-64.
13. Nasri, H., S. Shirani and A. Baradaran, 2006b. Pulmonary artery pressure in maintenance hemodialysis patients. Pak. J. Biol. Sci., 9: 107-110.
14. Ortega, O., I. Rodriguez, P. Gallar, A. Carreno and M. Ortiz et al., 2002. Significance of high C-reactive protein levels in pre-dialysis patients. Nephrol. Dial. Transplant., 17: 1105-1109.
15. Pecoits-Filho, R, P. Barany, B. Lindholm, O. Heimburger and P. Stenvinkel, 2002. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol. Dial. Transplant., 17: 1684-1688.
16. Racki, S., L. Zaputovic, Z. Mavric, B. Vujicic and S. Dvornik, 2006. C-reactive protein is a strong predictor of mortality in hemodialysis patients. Renal. Fail., 28: 427-433.
17. Razeghi, E., H. Omati, S. Maziar, P. Khashayar and M. Mahdavi-Mazeh, 2008. Chronic inflammation increases risk in hemodialysis patients. Saudi. J. Kidney. Dis. Trans., 19: 785-789.
18. Selim, G., O. Stojceva-Taneva, k. Zafirovska, A. Sikole, S. Gelev et al., 2006. Inflamation predicts all-cause and cardiovascular mortality in haemodialysis patients. Biol. Med. Sci., 27: 133-144.
19. Teruel, J.L., R. Marcen, J. Ocana, M. Femandez-Lucas, M. Rivera, G. Tabemero and J. Ortuno, 2005. Clinical significance of C-Reactive protein in patients on hemodialysis: A longitudinal study. Nephron. Clin. Prac., 100: 140-145.
20. Wanner, C. and T. Metzger, 2002. C-reactive protein a marker for all-cause and cardiovascular mortality in hemodialysis patients. Nephrol. Dial. Transplant., 17: 29-32.
21. Yao, Q., B. Lindholm and P. Stenvinkel, 2004. Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease and poor outcome in hemodialysis patients. Hemodialysis. Int., 8: 118-129.
22. Yeun, J.Y., R.A. Levine, V. Mantadilok and G.A. Kaysen, 2000. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am. J. Kidney Dis., 35: 469-476.
23. Yilmaz, M.I., 2007. The causes of the inflammation and possible therapeutic options in dialysis patients. Gulhane Med. J., 49: 271-276.
24. Zimmermann, J., S. Herrlinger, A. Pruy, T. Metzger and C. Wanner, 1999. Inflamation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney. Int., 55: 648-658.